Cyclosporin A-Sensitive Transcription Factor Egr-3 Regulates Fas Ligand Expression

REFERENCES

• Anel, A., M. Buferne, C. Boyer, A. M. Schmitt-Verhulst, and P. Golstein 1994. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur. J. Immunol. 24: 2469–2476.
   PubMed Web of Science ®Google Scholar
• Arase, H., N. Arase, and T. Saito 1995. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 181: 1235–1238.
   PubMed Web of Science ®Google Scholar
• Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl 1997. Current protocols in molecular biology 9 John Wiley & Sons, Inc., New York, N.Y.
   Google Scholar
• Bäumler, C. B., T. Böhler, I. Herr, A. Benner, P. H. Krammer, and K.-M. Debatin 1996. Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children. Blood 88: 1741–1746.
   PubMedGoogle Scholar
• Bellgrau, D., D. Gold, H. Selawry, J. Moore, A. Franzusoff, and R. C. Duke 1995. A role for CD95 ligand in preventing graft rejection. Nature 377: 630–632.
   PubMed Web of Science ®Google Scholar
• Boshart, M., F. Weber, G. Jahn, K. Dorsch-Hasler, B. Fleckenstein, and W. Schaffner 1985. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 41: 521–530.
   PubMed Web of Science ®Google Scholar
• Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, and D. R. Green 1995. Cell-autonomous Fas CD95/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373: 441–444.
   PubMed Web of Science ®Google Scholar
• Brunner, T., N. J. Yoo, D. LaFace, C. F. Ware, and D. R. Green 1996. Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506. Int. Immunol. 8: 1017–1026.
   PubMedGoogle Scholar
• Cao, X. M., R. A. Koski, A. Gashler, M. McKiernan, C. F. Morris, R. Gaffney, R. V. Hay, and V. P. Sukhatme 1990. Identification and characterization of the Egr-1 gene product, a DNA-binding zinc finger protein induced by differentiation and growth signals. Mol. Cell. Biol. 10: 1931–1939.
   PubMed Web of Science ®Google Scholar
• Chervonsky, A. V., Y. Wany, F. S. Wong, I. Visintin, R. A. Flavell, Janeway C. A., Jr., and L. A. Matis 1997. The role of Fas in autoimmune diabetes. Cell 89: 17–24.
   PubMed Web of Science ®Google Scholar
• Church, G. M., and W. Gilbert 1984. Genomic sequencing. Proc. Natl. Acad. Sci. USA 81: 1991–1995.
   PubMed Web of Science ®Google Scholar
• Crispe, I. N. 1994. Fatal interactions: Fas-induced apoptosis of mature T cells. Immunity 1: 347–349.
   PubMed Web of Science ®Google Scholar
• Crosby, S. D., J. J. Puetz, K. S. Simburger, T. J. Fahrner, and J. Milbrandt 1991. The early response gene NGFI-C encodes a zinc finger transcriptional activator and is a member of the GCGGGGGCG (GSG) element-binding protein family. Mol. Cell. Biol. 11: 3835–3841.
   PubMed Web of Science ®Google Scholar
• Driggers, P. H., D. L. Ennist, S. L. Gleason, W. H. Mak, M. S. Marks, B. Z. Levi, J. R. Flanagan, E. Appella, and K. Ozato 1990. An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc. Natl. Acad. Sci. USA 87: 3743–3747.
   PubMed Web of Science ®Google Scholar
• Fisher, G. H., F. J. Rosenberg, S. E. Straus, J. K. Dale, L. A. Middelton, A. Y. Lin, W. Strober, M. J. Lenardo, and J. M. Puck 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81: 935–946.
   PubMed Web of Science ®Google Scholar
• Gashler, A., and V. P. Sukhatme 1995. Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog. Nucleic Acid Res. Mol. Biol. 50: 191–224.
   PubMed Web of Science ®Google Scholar
• Giordano, C., G. Stassi, R. De Maria, M. Todaro, P. Richiusa, G. Papoff, G. Ruberti, M. Bagnasco, R. Testi, and A. Galluzzo 1997. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto’s thyroiditis. Science 275: 960–963.
   PubMed Web of Science ®Google Scholar
• Griffith, T. S., T. Brunner, S. M. Fletcher, D. R. Green, and T. A. Ferguson 1995. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189–1192.
   PubMed Web of Science ®Google Scholar
• Griffith, T. S., X. Yu, J. M. Herndon, D. R. Green, and T. A. Ferguson 1996. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity 5: 7–16.
   PubMed Web of Science ®Google Scholar
• Gupta, M. P., M. Gupta, R. Zak, and V. P. Sukhatme 1991. Egr-1, a serum-inducible zinc finger protein, regulates transcription of the rat cardiac alpha-myosin heavy chain gene. J. Biol. Chem. 266: 12813–12816.
   PubMed Web of Science ®Google Scholar
• Hahne, M., D. Rimoldi, M. Schroter, P. Romero, M. Schreier, L. E. French, P. Schneider, T. Bornand, A. Fontana, D. Lienard, J. Cerottini, and J. Tschopp 1996. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science 274: 1363–1366.
   PubMed Web of Science ®Google Scholar
• Hedrick, S. M., L. A. Matis, T. T. Hecht, L. E. Samelson, D. L. Longo, E. Heber-Katz, and R. H. Schwartz 1982. The fine specificity of antigen and Ia determinant recognition by T cell hybridoma clones specific for pigeon cytochrome c. Cell 30: 141–152.
   PubMed Web of Science ®Google Scholar
• Hodge, M. R., A. M. Ranger, F. Charles de la Brousse, T. Hoey, M. J. Grusby, and L. H. Glimcher 1996. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 4: 397–405.
   PubMed Web of Science ®Google Scholar
• Holtz-Heppelmann, C. J., A. Algeciras, A. D. Badley, and C. V. Paya 1998. Transcriptional regulation of the human FasL promoter-enhancer region. J. Biol. Chem. 273: 4416–4423.
   PubMedGoogle Scholar
• Horton, R. M., Z. L. Cai, S. N. Ho, and L. R. Pease 1990. Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. BioTechniques 8: 528–535.
   PubMed Web of Science ®Google Scholar
• Jain, J., P. G. McCaffrey, Z. Miner, T. K. Kerppola, J. N. Lambert, G. L. Verdine, T. Curran, and A. Rao 1993. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 365: 352–355.
   PubMed Web of Science ®Google Scholar
• Ju, S.-T., D. J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marchak-Rothstein 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373: 444–448.
   PubMed Web of Science ®Google Scholar
• Ju, S. T., H. Cui, D. J. Panka, R. Ettinger, and A. Marshak-Rothstein 1994. Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells. Proc. Natl. Acad. Sci. USA 91: 4185–4189.
   PubMed Web of Science ®Google Scholar
• Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein 1994. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265: 528–530.
   PubMed Web of Science ®Google Scholar
• Katsikis, P. D., E. S. Wunderlich, C. A. Smith, L. A. Herzenberg, and L. A. Herzenberg 1995. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181: 2029–2036.
   PubMed Web of Science ®Google Scholar
• Kramer, B., A. Meichle, G. Hensel, P. Charnay, and M. Kronke 1994. Characterization of a Krox-24/Egr-1-responsive element in the human tumor necrosis factor promoter. Biochim. Biophys. Acta 1219: 413–421.
   PubMedGoogle Scholar
• Kung, P., G. Goldstein, E. L. Reinherz, and S. F. Schlossman 1979. Monoclonal antibodies defining distinctive human T cell surface antigens. Science 206: 347–349.
   PubMed Web of Science ®Google Scholar
• Latinis, K. M., L. L. Carr, E. J. Peterson, L. A. Norian, S. L. Eliason, and G. A. Koretzky 1997. Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. J. Immunol. 158: 4602–4611.
   PubMedGoogle Scholar
• Latinis, K. M., L. A. Norian, S. L. Eliason, and G. A. Koretzky 1997. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J. Biol. Chem. 272: 31427–31434.
   PubMedGoogle Scholar
• Lee, S. L., L. C. Tourtellotte, R. L. Wesselschmidt, and J. Milbrandt 1995. Growth and differentiation proceeds normally in cells deficient in the immediate early gene NGFI-A. J. Biol. Chem. 270: 9971–9977.
   PubMed Web of Science ®Google Scholar
• Leo, O., M. Foo, D. H. Sachs, L. E. Samelson, and J. A. Bluestone 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA 84: 1374–1378.
   PubMed Web of Science ®Google Scholar
• Lin, J. X., and W. J. Leonard 1997. The immediate-early gene product Egr-1 regulates the human interleukin-2 receptor beta-chain promoter through noncanonical Egr and Sp1 binding sites. Mol. Cell. Biol. 17: 3714–3722.
   PubMedGoogle Scholar
• Liu, C., E. Adamson, and D. Mercola 1996. Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor beta 1. Proc. Natl. Acad. Sci. USA 93: 11831–11836.
   PubMed Web of Science ®Google Scholar
• Lynch, D. H., M. L. Watson, M. R. Alderson, P. R. Baum, R. E. Miller, T. Tough, M. Gibson, T. Davis-Smith, C. A. Smith, K. Hunter, D. Bhat, W. Din, R. G. Goodwin, and M. F. Seldin 1994. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1: 131–136.
   PubMed Web of Science ®Google Scholar
• Mages, H. W., T. Stamminger, O. Rilke, R. Bravo, and R. A. Kroczek 1993. Expression of PILOT, a putative transcription factor, requires two signals and is cyclosporin A sensitive in T cells. Int. Immunol. 5: 63–70.
   PubMedGoogle Scholar
• Maltzman, J. S., J. A. Carman, and J. G. Monroe 1996. Role of EGR1 in regulation of stimulus-dependent CD44 transcription in B lymphocytes. Mol. Cell. Biol. 16: 2283–2294.
   PubMedGoogle Scholar
• Maltzman, J. S., J. A. Carman, and J. G. Monroe 1996. Transcriptional regulation of the Icam-1 gene in antigen receptor- and phorbol ester-stimulated B lymphocytes: role for transcription factor EGR1. J. Exp. Med. 183: 1747–1759.
   PubMed Web of Science ®Google Scholar
• Mercep, M., P. D. Noguchi, and J. D. Ashwell 1989. The cell cycle block and lysis of an activated T cell hybridoma are distinct processes with different Ca2+ requirements and sensitivity to cyclosporine A. J. Immunol. 142: 4085–4092.
   PubMed Web of Science ®Google Scholar
• Molnar, G., A. Crozat, and A. B. Pardee 1994. The immediate-early gene Egr-1 regulates the activity of the thymidine kinase promoter at the G0-to-G1 transition of the cell cycle. Mol. Cell. Biol. 14: 5242–5248.
   PubMedGoogle Scholar
• Moreno, M. B., S. A. Memon, and C. M. Zacharchuk 1996. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1β-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity. J. Immunol. 157: 3845–3849.
   PubMedGoogle Scholar
• Nagata, S. 1997. Apoptosis by death factor. Cell 88: 355–365.
   PubMed Web of Science ®Google Scholar
• Nelson, N., Y. Kanno, C. Hong, C. Contursi, T. Fujita, B. J. Fowlkes, E. O’Connell, J. Hu-Li, W. E. Paul, D. Jankovic, A. F. Sher, J. E. Coligan, A. Thornton, E. Appella, Y. Yang, and K. Ozato 1996. Expression of IFN regulatory factor family proteins in lymphocytes. Induction of Stat-1 and IFN consensus sequence binding protein expression by T cell activation. J. Immunol. 156: 3711–3720.
   PubMedGoogle Scholar
• O’Connell, J., G. C. O’Sullivan, J. K. Collins, and F. Shanahan 1996. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J. Exp. Med. 184: 1075–1082.
   PubMed Web of Science ®Google Scholar
• Patwardhan, S., A. Gashler, M. G. Siegel, L. C. Chang, L. J. Joseph, T. B. Shows, M. M. Le Beau, and V. P. Sukhatme 1991. EGR3, a novel member of the Egr family of genes encoding immediate-early transcription factors. Oncogene 6: 917–928.
   PubMed Web of Science ®Google Scholar
• Rieux-Laucat, F., F. Le Deist, C. Hivroz, I. A. G. Roberts, K. M. Debatin, A. Fischer, and J. P. de Villartay 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268: 1347–1349.
   PubMed Web of Science ®Google Scholar
• Russo, M. W., C. Matheny, and J. Milbrandt 1993. Transcriptional activity of the zinc finger protein NGFI-A is influenced by its interaction with a cellular factor. Mol. Cell. Biol. 13: 6858–6865.
   PubMed Web of Science ®Google Scholar
• Russo, M. W., B. R. Sevetson, and J. Milbrandt 1995. Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription. Proc. Natl. Acad. Sci. USA 92: 6873–6877.
   PubMed Web of Science ®Google Scholar
• Shao, H., D. H. Kono, L. Y. Chen, E. M. Rubin, and J. Kaye 1997. Induction of the early growth response Egr family of transcription factors during thymic selection. J. Exp. Med. 185: 731–744.
   PubMedGoogle Scholar
• Skerka, C., E. L. Decker, and P. F. Zipfel 1995. A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1. J. Biol. Chem. 270: 22500–22506.
   PubMed Web of Science ®Google Scholar
• Strand, S., W. J. Hofmann, H. Hug, M. Muller, G. Otto, D. Strand, S. M. Mariani, W. Stremmel, P. H. Krammer, and P. R. Galle 1996. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells—a mechanism of immune evasion? Nat. Med. 2: 1361–1366.
   PubMed Web of Science ®Google Scholar
• Sukhatme, V. P., S. Kartha, F. G. Toback, R. Taub, R. G. Hoover, and C. H. Tsai-Morris 1987. A novel early growth response gene rapidly induced by fibroblast, epithelial cell and lymphocyte mitogens. Oncogene Res. 1: 343–355.
   PubMedGoogle Scholar
• Svaren, J., B. R. Sevetson, E. D. Apel, D. B. Zimonjic, N. C. Popescu, and J. Milbrandt 1996. NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Mol. Cell. Biol. 16: 3545–3553.
   PubMed Web of Science ®Google Scholar
• Swirnoff, A. H., and J. Milbrandt 1995. DNA-binding specificity of NGFI-A and related zinc finger transcription factors. Mol. Cell. Biol. 15: 2275–2287.
   PubMed Web of Science ®Google Scholar
• Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76: 969–976.
   PubMed Web of Science ®Google Scholar
• Takahashi, T., M. Tanaka, J. Inazawa, T. Abe, T. Suda, and S. Nagata 1994. Human Fas ligand: gene structure, chromosomal location, and species specificity. Int. Immunol. 6: 1567–1574.
   PubMed Web of Science ®Google Scholar
• Tatarowicz, W. A., C. E. Martin, A. S. Pekosz, S. L. Madden, Rauscher F. J., 3rd, S. Y. Chiang, T. A. Beerman, and N. W. Fraser 1997. Repression of the HSV-1 latency-associated transcript (LAT) promoter by the early growth response (EGR) proteins: involvement of a binding site immediately downstream of the TATA box. J. Neurovirol. 3: 212–224.
   PubMed Web of Science ®Google Scholar
• Van Parijs, L., A. Ibraghimov, and A. K. Abbas 1996. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4: 321–328.
   PubMed Web of Science ®Google Scholar
• Wang, Z. Y., and T. F. Deuel 1992. An S1 nuclease-sensitive homopurine/homopyrimidine domain in the PDGF A- chain promoter contains a novel binding site for the growth factor-inducible protein EGR-1. Biochem. Biophys. Res. Commun. 188: 433–439.
   PubMedGoogle Scholar
• Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314–317.
   PubMed Web of Science ®Google Scholar
• Westendorp, M. O., R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Walczak, K.-M. Debatin, and P. H. Krammer 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375: 497–500.
   PubMed Web of Science ®Google Scholar
• Yang, Y., Z.-H. Liu, C. F. Ware, and J. D. Ashwell 1997. A cysteine protease inhibitor prevents activation-induced T cell apoptosis and death of peripheral blood cells from HIV-infected individuals by inhibiting upregulation of Fas ligand. Blood 89: 550–557.
   PubMedGoogle Scholar
• Yang, Y., M. Mercep, C. F. Ware, and J. D. Ashwell 1995. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J. Exp. Med. 181: 1673–1682.
   PubMedGoogle Scholar